Gen9 gets $25M in equity funding for DNA synthesis By: Boston Business Journal via Business Journals July 31, 2014 at 07:28 AM EDT Gen9, a Cambridge-based synthetic biology co-founded in 2009 by Harvard professor George Church, has filed for the receipt of $25 million in equity... Read More >> Related Stocks: Agilent Technologies